ProAir RespiClick inhalation powder; QVAR for treatment for asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax, an inhaled corticosteroid and ...

Last year saw a key development in the US respiratory diseases market when Mylan finally launched its generic version of GlaxoSmithKline’s blockbuster inhaler Advair (fluticasone+salmeterol).

Subjects were then randomised to receive either an extra inhalation of the same dose ... muscle cramps and headache) and fluticasone propionate-related events (oral candidiasis and hoarseness ...

The Annals of Pharmacotherapy. 2009;43(3):519-527.

The main patent on Advair (fluticasone+salmeterol) expired as long ago as 2010, while the patent on GSK’s Diskus inhaler expired in 2016. But Mylan became the first of a group of potential ...

In a “true pivot” in asthma care across the UK, new guidelines urge medics to offer inhalers that both relieve and prevent symptoms to newly diagnosed sufferers who are 12 and over ...

After hours: November 27 at 7:43 p.m. EST ...

But it is young Gitesh that has the family worried. “A non-smoker, he has a severe dust allergy. He takes anti-allergens and has been on inhalers for the last 10 years,” says Sanjay. “I get breathless ...